COVID Vaccine Timing in Menstrual Cycle Affects
Get the Health newsletter
Daily health & science — research, biotech, public health, the studies worth knowing. Free.
- Poppy Cooper and colleagues at the London School of Hygiene & Tropical Medicine analyzed data from 1,474 women across the US, UK, Canada, and Australia who used the Clue period-tracking app in 2021, finding breakthrough COVID-19 infections occurred 35 days earlier among those vaccinated during the luteal phase versus the follicular phase.
- Julia Craggs, a women's health doctor, said progesterone — elevated in the luteal phase — may suppress aggressive immune responses like T cell activity, potentially blunting vaccine training at exactly the wrong moment.
- The study, published in npj Women's Health, captured 82 self-reported breakthrough infections among women vaccinated mostly with Pfizer or Moderna, though infections were not PCR-confirmed.
- The researchers, some of whom work for Clue, acknowledged limitations: the observational design doesn't prove the menstrual cycle directly causes the effect, and two of the four cycle stages — menses and ovulation — were not analyzed.
- Cooper is now investigating whether hormonal contraceptives affect vaccine outcomes and said she'd like to see the same menstrual-cycle question asked across other vaccines and medical interventions.
- Earlier 2021 reports suggested COVID vaccines temporarily altered period heaviness and timing, though a later study found any such changes were small and short-lived.
Why it matters: The study signals that progesterone's immune-dampening role during the luteal phase may be an overlooked variable in vaccine and drug research. With only 82 breakthrough infections and no PCR confirmation, the finding isn't practice-changing yet — but Cooper's team is now extending the work to hormonal contraceptives and other vaccines, potentially unlocking answers about unexplained variation in how women respond to medical interventions.
